Biotech startup Zymergen nabs $130 million from Softbank

 Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank. For those unfamiliar, the company makes crazy new materials out of genetically altered microbes. It was busy buying up a bunch of robots to make these microbes for mass production of various materials during its last round of funding. CEO… Read More

http://ift.tt/2dgEfd4 Biotech startup Zymergen nabs $130 million from Softbank http://ift.tt/2dHxhRF